This trend was not observed when we compared KLF5 expression between non-COVID-19 pneumonia patients with variable severity (Supplementary Fig. 5), suggesting a specific role of KLF5 as an anti-viral factor in modulating disease severity of COVID-19 patients. The gene discussed is KLF5; the disease is COVID-19.